Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

Quantifying heterogeneity in a meta‐analysis

Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763

Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies

Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602

The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>

Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104

QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1

GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644

HPV Screening for Cervical Cancer in Rural India

Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,278

Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer

Mayrand, M., Duarte‐Franco, E., Rodrigues, I., Walter, S. D., Hanley, J. A., Ferenczy, A. S., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,106

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

Ronco, G., Rossi, P. G., Carozzi, F., Confortini, M., Palma, P. D., Mistro, A. D., Ghiringhello, B., Girlando, S., Gillio‐Tos, A., Marco, L. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 955

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897

Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

Nauclér, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073204 · Cited by 797

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document

Arbyn, M., Anttila, A., Jordan, J. A., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 762

Sensitivity of APTIMA HPV E6/E7 mRNA test in comparison with hybrid capture 2 HPV DNA test for detection of high risk oncogenic human papillomavirus in 396 biopsy confirmed cervical cancers

Basu, P. S., Banerjee, D., Mittal, S., Dutta, S., Ghosh, I., Chowdhury, N., Abraham, P., Chandna, P., & Ratnam, S. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24453 · Cited by 19

Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program

Tranberg, M., Bech, B. H., Blaakær, J., Jensen, J. S., Svanholm, H., & Andersen, B. S. (2016) · BMC Cancer · doi:10.1186/s12885-016-2859-z · Cited by 20

A 3‐year interval is too short for re‐screening women testing negative for human papillomavirus: a population‐based cohort study

Zorzi, M., Frayle, H., Rizzi, M., Fedato, C., Rugge, M., Penon, M. G., Bertazzo, A., Callegaro, S., Campagnolo, M., Ortu, F., et al. (2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14575 · Cited by 19

Risk stratification in cervical cancer screening by complete screening history: Applying bioinformatics to a general screening population

Baltzer, N., Sundström, K., Nygård, J. F., Dillner, J., & Komorowski, J. (2017) · International Journal of Cancer · doi:10.1002/ijc.30725 · Cited by 19

Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women

Aoyama‐Kikawa, S., Fujita, H., Hanley, S. J. B., Kasamo, M., Kikuchi, K., Torigoe, T., Matsuno, Y., Tamakoshi, A., Sasaki, T., Matsuura, M., et al. (2018) · Cancer Science · doi:10.1111/cas.13608 · Cited by 19

High-risk Human Papillomavirus Messenger RNA Testing in Wet and Dry Self-collected Specimens for High-grade Cervical Lesion Detection in Mombasa, Kenya

Islam, J. Y., Mutua, M., Kabare, E., Manguro, G., Hudgens, M. G., Poole, C., Olshan, A. F., Wheeler, S. B., McClelland, R. S., & Smith, J. S. (2020) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001167 · Cited by 20

COLPOSCOPY PROTOCOLS 2020

Jach, R., Mazurec, M., Trzeszcz, M., Bartosińska-Dyc, A., Galarowicz, B., Kędzia, W., Nowakowski, A. M., & Pityński, K. (2020) · Ginekologia Polska · doi:10.5603/gp.2020.0075 · Cited by 20

De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening

Hahn, E. E., Munoz‐Plaza, C. E., Altman, D. E., Hsu, C., Cannizzaro, N. T., Ngo‐Metzger, Q., Wride, P., Gould, M. K., Mittman, B. S., Hodeib, M., et al. (2021) · Implementation Science Communications · doi:10.1186/s43058-021-00211-z · Cited by 19

A Gene Signature Identifying CIN3 Regression and Cervical Cancer Survival

Halle, M. K., Munk, A. C., Engesæter, B. Ø., Akbari, S., Frafjord, A., Høivik, E. A., Forsse, D., Fasmer, K. E., Woie, K., Haldorsen, I. S., et al. (2021) · Cancers · doi:10.3390/cancers13225737 · Cited by 19

Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples

Avian, A., Clemente, N., Mauro, E., Isidoro, E., Napoli, M. D., Dudine, S., Fabro, A. D., Morini, S., Perin, T., Giudici, F., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03383-x · Cited by 21

Tumor DNA Methylation Profiles Enable Diagnosis, Prognosis Prediction, and Screening for Cervical Cancer

Tu, J., Chen, S., Wu, S., Wu, T., Fan, R., & Kuang, Z. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s352373 · Cited by 19

Primary HPV testing: U.S. women's awareness and acceptance of an emerging screening modality

Saraiya, M., Kwan, A. K., & Cooper, C. P. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.12.007 · Cited by 19

Atypical squamous cells of undetermined significance cervical cytology in the Chinese population: Age‐stratified reporting rates, high‐risk HPV testing, and immediate histologic correlation results

Tao, X., Zhang, H., Wang, L., Pan, Q., Ji, S., Zhou, X., & Zhao, C. (2020) · Cancer Cytopathology · doi:10.1002/cncy.22333 · Cited by 19

Urine testing for HPV

Kitchener, H. C., & Owens, G. L. (2014) · BMJ · doi:10.1136/bmj.g5542 · Cited by 20

A first survey of HPV-based screening in routine cervical cancer screening in Italy.

Ronco, G., Rossi, P. G., Giubilato, P., Mistro, A. D., Zappa, M., & Carozzi, F. M. (2015) · PubMed · Cited by 19

Self-sampling HPV test in women not undergoing Pap smear for more than 5 years and factors associated with under-screening in Taiwan

Chou, H., Huang, H., Cheng, H.-H., Chang, C., Yang, L., Huang, C.-C., Chang, W., Hsueh, S., Chao, A., Wang, C., et al. (2015) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2015.10.014 · Cited by 18

Persistence and clearance of high‐risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study

Luckett, R. L., Painter, H., Hacker, M. R., Simon, B., Seiphetlheng, A., Erlinger, A., Eakin, C. M., Moyo, S. M., Kyokunda, L., Esselen, K. M., et al. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16758 · Cited by 19

Atypical glandular cells and development of cervical cancer: Population‐based cohort study

Norman, I., Yilmaz, E., Hjerpe, A., Hortlund, M., Elfström, K. M., & Dillner, J. (2022) · International Journal of Cancer · doi:10.1002/ijc.34242 · Cited by 18

Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States

Cuzick, J. M., Adcock, R., Kinney, W., Castle, P. E., Robertson, M., McDonald, R. M., Stoler, M. H., Du, R., & Wheeler, C. M. (2023) · International Journal of Cancer · doi:10.1002/ijc.34519 · Cited by 19

Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019–2020)

Mwenda, V., Bor, J., Nyangasi, M. F., Njeru, J., Olwande, S., Njiri, P., Arbyn, M., Weyers, S., Tummers, P., & Temmerman, M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0286202 · Cited by 18

First international proficiency study on human papillomavirus testing in cervical cancer screening

Yilmaz, E., Eklund, C., Lagheden, C., Robertsson, K. D., Lilja, M., Elfström, M. K., Mühr, L. S. A., & Dillner, J. (2023) · Journal of Clinical Virology · doi:10.1016/j.jcv.2023.105581 · Cited by 18

Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening

Cho, E. H., Park, M., Woo, H., Park, H., & Kwon, M. (2024) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2024.35.e72 · Cited by 18

Embracing a new era in cervical cancer screening

Isidean, S. D., & Franco, E. L. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62028-0 · Cited by 18

HPV testing for primary cervical screening: Laboratory issues and evolving requirements for robust quality assurance

Carozzi, F. M., Mistro, A. D., Cuschieri, K. S., Frayle, H., Sani, C., & Burroni, E. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.10.025 · Cited by 18

Detection of HPV subtypes by mass spectrometry in FFPE tissue specimens: a reliable tool for routine diagnostics

Kriegsmann, M., Wandernoth, P., Lisenko, K., Casadonte, R., Longuespée, R., Arens, N., & Kriegsmann, J. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2016-204017 · Cited by 19

Performance of OncoE6TMCervical Test in detecting cervical precancer lesions in HIV-positive women attending an HIV clinic in Bujumbura, Burundi: a cross-sectional study

Ndizeye, Z., Menon, S., Geertruyden, J. V., Sauvaget, C., Jacquemyn, Y., Bogers, J., Benoy, I. H., & Broeck, D. V. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-029088 · Cited by 18

A roadmap for a comprehensive control of cervical cancer in Poland: integration of available solutions into current practice in primary and secondary prevention

Nowakowski, A. M., Arbyn, M., Turkot, M. H., Wieszczy, P., Miłosz, K., Kaminski, M. F., Didkowska, J. A., Bidziński, M., Olszewski, W. T., Wielgoś, M., et al. (2019) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000528 · Cited by 18

Performance of vaginal self-sampling for human papillomavirus testing among women living with HIV in Botswana

Elliott, T., Kohler, R. E., Monare, B., Moshashane, N., Ramontshonyana, K., Muthoga, C. W., Wynn, A., Howett, R., Luckett, R. L., Morroni, C., et al. (2019) · International Journal of STD & AIDS · doi:10.1177/0956462419868618 · Cited by 18

Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention

Surriabre, P., Torrico, A., Vargas, T., Ugarte, F., Rodríguez, P., & Fontaine, V. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4527-9 · Cited by 18

Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges

Pimple, S. A., & Mishra, G. A. (2019) · Minerva Obstetrics and Gynecology · doi:10.23736/s0026-4784.19.04468-x · Cited by 18

Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women

Louvanto, K., Eriksson, T., Gray, P. G., Apter, D. L., Baussano, I., Bly, A., Harjula, K., Heikkilä, K., Hokkanen, M., Huhtinen, L., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32802 · Cited by 20

Risk of cervical lesions in high-risk HPV positive women with normal cytology: a retrospective single-center study in China

Wang, Z., Liu, T., Wang, Y., Gu, Y., Wang, H., Liu, J., Cui, B., & Yang, X. (2020) · Infectious Agents and Cancer · doi:10.1186/s13027-020-00291-x · Cited by 18

Association of cervicovaginal dysbiosis mediated HPV infection with cervical intraepithelial neoplasia

Kumari, S., & Bhor, V. M. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104780 · Cited by 18

The Influence of Sexual Behavior and Demographic Characteristics in the Expression of HPV-Related Biomarkers in a Colposcopy Population of Reproductive Age Greek Women

Valasoulis, G., Pouliakis, A., Michail, G., Daponte, A., Galazios, G. C., Panayiotides, I. G., & Daponte, A. I. (2021) · Biology · doi:10.3390/biology10080713 · Cited by 18

Epidemiological study of HPV infection in 40,693 women in Putian: a population study based on screening for high-risk HPV infection

Chen, Z., Lin, H., Zheng, J., Cai, L., Chen, Z., Li, J., & Yu, L. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07893-3 · Cited by 18

Comparison of the Abbott RealTime High Risk HPV test and the Roche cobas 4800 HPV test using urine samples

Lim, M. C., Lee, D. H., Hwang, S., Hwang, N. R., Lee, B., Shin, H. Y., Jun, J. K., Yoo, C. W., Lee, D. O., Seo, S., et al. (2017) · Journal of Virological Methods · doi:10.1016/j.jviromet.2017.01.020 · Cited by 18

Primary, secondary and tertiary prevention of human papillomavirus-driven head and neck cancers

Mirghani, H., Jung, A. C., & Fakhry, C. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.03.021 · Cited by 18

Initial prevalence of anal human papilloma virus infection in liver transplant recipients

Grąt, M., Grąt, K., Hołówko, W., Malejczyk, M., de Walthoffen, S. W., Lewandowski, Z., Kobryń, K., Patkowski, W., Majewski, S. T., Młynarczyk, G., et al. (2014) · Transplant International · doi:10.1111/tri.12339 · Cited by 18

HPV primary cervical screening: time for a change

Kitchener, H. C. (2015) · Cytopathology · doi:10.1111/cyt.12236 · Cited by 18

Primary HPV testing: a proposal for co‐testing in initial rounds of screening to optimise sensitivity of cervical cancer screening

Herbert, A. (2016) · Cytopathology · doi:10.1111/cyt.12334 · Cited by 17

Optimization of droplet digital PCR assays for the type-specific detection and quantification of five HPV genotypes, including additional data on viral loads of nine different HPV genotypes in cervical carcinomas

Kaliff, M., Mordhorst, L. B., Helenius, G., Mats, K. G., & Larsson, G. L. (2021) · Journal of Virological Methods · doi:10.1016/j.jviromet.2021.114193 · Cited by 17

Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population

Gustinucci, D., Benevolo, M., Cesarini, E. N., Mancuso, P., Passamonti, B. U., Giaimo, M. D., Corvetti, R., Nofrini, V., Bulletti, S., Malaspina, M., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33858 · Cited by 17

Testing key messages about extending cervical screening intervals

Marlow, L. A. V., Nemec, M., Barnes, J., & Waller, J. (2022) · Patient Education and Counseling · doi:10.1016/j.pec.2022.04.006 · Cited by 17

A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care

Chang, M. M., Ma, A., Novak, E. N., Barra, M., Kundrod, K. A., Montealegre, J. R., Scheurer, M. E., Castle, P. E., Schmeler, K. M., & Richards-Kortum, R. R. (2023) · Scientific Reports · doi:10.1038/s41598-023-47582-y · Cited by 19

Primary human papillomavirus screening for cervical cancer in the United States—US Food and Drug Administration approval, clinical trials, and where we are today

Nayar, R., Goulart, R. A., Tiscornia-Wasserman, P. G., & Davey, D. D. (2014) · Cancer Cytopathology · doi:10.1002/cncy.21480 · Cited by 17

Cervical Precancer and Cancer Risk by Human Papillomavirus Status and Cytologic Interpretation: Implications for Risk-Based Management

Castle, P. E., Aslam, S., & Behrens, C. M. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0330 · Cited by 17

Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records

Landy, R., Cheung, L. C., SCHIFFMAN, M. H., Gage, J. C., Hyun, N., Wentzensen, N., Kinney, W., Castle, P. E., Fetterman, B. J., Poitras, N. E., et al. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.12.004 · Cited by 17

Protocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda

Murenzi, G., Dusingize, J. C., Rurangwa, T., Sinayobye, J. D., Munyaneza, A., Murangwa, A., Muvunyi, T. Z., Hébert, T. M., Mugenzi, P., Adedimeji, A., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020432 · Cited by 17

(At Least) Once in Her Lifetime: Global Cervical Cancer Prevention

Castle, P. E., & Pierz, A. J. (2019) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2018.09.007 · Cited by 18

Population-based primary HPV mRNA cervical screening compared with cytology screening

Lindroth, Y., Borgfeldt, C., Thorn, G., Bodelsson, G., & Forslund, O. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.04.021 · Cited by 17

Low-Risk Human Papillomavirus Types in Cervical Intraepithelial Neoplasia 2–3 and in Invasive Cervical Cancer Patients

Siegler, E., Reichman, Y., Kugelman, N., Mackuli, L., Lavie, O., Ostrovsky, L., Shaked‐Mishan, P., & Segev, Y. (2019) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000486 · Cited by 17

Anal squamous intraepithelial lesions: an update and proposed management algorithm

Chittleborough, T. J., Tapper, R. I., Eglinton, T. W., & Frizelle, F. (2019) · Techniques in Coloproctology · doi:10.1007/s10151-019-02133-4 · Cited by 17

Comparison of vaginal self‐sampling and cervical sampling by medical professionals for the detection of HPV and CIN2 +: A randomized study

Aarnio, R., Isacson, I., Sanner, K., Gustavsson, I. M., Gyllensten, U. B., & Olovsson, M. (2021) · International Journal of Cancer · doi:10.1002/ijc.33482 · Cited by 19

Type-specific Distribution of Cervical hrHPV Infection and the Association with Cytological and Histological Results in a Large Population-based Cervical Cancer Screening Program: Baseline and 3-year Longitudinal Data

Song, F., Du, H., Xiao, A., Wang, C., Huang, X., Liu, Z., Zhao, M., Men, H., & Wu, R. (2020) · Journal of Cancer · doi:10.7150/jca.48357 · Cited by 17

Australian National Cervical Screening Program renewal: Attitudes and experiences of general practitioners, and obstetricians and gynaecologists

Obermair, H., Bennett, K. F., Brotherton, J. M. L., Smith, M. A., McCaffery, K. J., & Dodd, R. H. (2021) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13310 · Cited by 17

Cervical cancer screening uptake and determinant factors among women in Ambo town, Western Oromia, Ethiopia: Community‐based cross‐sectional study

Natae, S. F., Nigatu, D. T., Negawo, M. K., & Mengesha, W. W. (2021) · Cancer Medicine · doi:10.1002/cam4.4369 · Cited by 17

Switching clinic‐based cervical cancer screening programs to human papillomavirus self‐sampling: A cost‐effectiveness analysis of vaccinated and unvaccinated Norwegian women

Pedersen, K., Portnoy, A., Sy, S., Hansen, B. T., Tropé, A., Kim, J. J., & Burger, E. A. (2021) · International Journal of Cancer · doi:10.1002/ijc.33850 · Cited by 17

Microwave-assisted synthesis of polypyridyl ruthenium( ii ) complexes as potential tumor-targeting inhibitors against the migration and invasion of Hela cells through G2/M phase arrest

Cao, J., Wu, Q., Zheng, W., Li, L., & Mei, W. (2017) · RSC Advances · doi:10.1039/c7ra00658f · Cited by 17

Screening women for cervical cancer carcinoma with a HPV mRNA test: first results from the Venice pilot program

Maggino, T., Sciarrone, R., Murer, B., Rossi, M. R. D., Fedato, C., Maran, M., Lorio, M., Soldà, M., Zago, F., Rossi, P. G., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.216 · Cited by 20

CITRUS, cervical cancer screening trial by randomization of HPV testing intervention for upcoming screening: Design, methods and baseline data of 18,471 women

Morisada, T., TERAMOTO, K., Takano, H., Sakamoto, I., Nishio, H., Iwata, T., Hashi, A., Katoh, R., Okamoto, A., Sasaki, H., et al. (2017) · Cancer Epidemiology · doi:10.1016/j.canep.2017.07.017 · Cited by 17

Raman spectral signatures of cervical exfoliated cells from liquid-based cytology samples

Kearney, P., Traynor, D., Bonnier, F., Lyng, F. M., O’Leary, J. J., & Martin, C. M. (2017) · Journal of Biomedical Optics · doi:10.1117/1.jbo.22.10.105008 · Cited by 17

Are Health Care Professionals Prepared to Implement Human Papillomavirus Testing? A Review of Psychosocial Determinants of Human Papillomavirus Test Acceptability in Primary Cervical Cancer Screening

Tatar, O., Wade, K., McBride, E., Thompson, E. L., Head, K. J., Perez, S., Shapiro, G. K., Waller, J., Zimet, G. D., & Rosberger, Z. (2019) · Journal of Women s Health · doi:10.1089/jwh.2019.7678 · Cited by 17

Cervical cancer screening

Singer, A., & Khan, A. (2018) · Wiley eBooks · doi:10.1002/9781118990957.ch8 · Cited by 17

The population impact of human papillomavirus/cytology cervical cotesting at 3‐year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen

Silver, M. I., SCHIFFMAN, M. H., Fetterman, B. J., Poitras, N. E., Gage, J. C., Wentzensen, N., Lorey, T. S., Kinney, W., & Castle, P. E. (2016) · Cancer · doi:10.1002/cncr.30277 · Cited by 16

Triaging HPV-Positive Cervical Samples with p16 and Ki-67 Dual Stained Cytology within an Organized Screening Program—A Prospective Observational Study from Western Norway

Øvestad, I. T., Dalen, I., Andersland, M. S., Vintermyr, O. K., Moltu, P., Berland, J. M., Janssen, E. A. M., & Haugland, H. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087158 · Cited by 16

Human Papilloma Virus DNA Detection in Clinical Samples Using Fluorogenic Probes Based on Oligonucleotide Gated Nanoporous Anodic Alumina Films

Hernández‐Montoto, A., Aranda, M. N., Caballos, I., López‐Palacios, A., Tormo‐Más, M. Á., Pemán, J., Rodríguez, M. P., Picornell, C., Aznar, E., & Martínez‐Máñez, R. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202203326 · Cited by 16

Long‐term prediction by DNA methylation of high‐grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort

Gilham, C., Nedjai, B., Scibior‐Bentkowska, D., Reuter, C., Banwait, R., Brentnall, A. R., Cuzick, J. M., Peto, J., & Lörincz, A. T. (2024) · International Journal of Cancer · doi:10.1002/ijc.34913 · Cited by 16

VTCNet : A Feature Fusion DL Model Based on CNN and ViT for the Classification of Cervical Cells

Li, M., Que, N., Zhang, J., Du, P., & Dai, Y. (2024) · International Journal of Imaging Systems and Technology · doi:10.1002/ima.23161 · Cited by 16

Production of functional, stable, unmutated recombinant human papillomavirus E6 oncoprotein: implications for HPV-tumor diagnosis and therapy

Illiano, E., Demurtas, O. C., Massa, S., Bonito, P. D., Consalvi, V., Chiaraluce, R., Zanotto, C., Morghen, C. D. G., Radaelli, A., Venuti, A., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0978-6 · Cited by 16

The Role of Cytology in the 21st Century: The Integration of Cells and Molecules

Bergeron, C., & Doeberitz, M. V. K. (2016) · Acta Cytologica · doi:10.1159/000449402 · Cited by 16

Self-collected cervicovaginal sampling for site-of-care primary HPV-based cervical cancer screening: a pilot study in a rural underserved Greek population

Chatzistamatiou, Κ., Chatzaki, Ε., Constantinidis, Τ., Nena, E., Tsertanidou, A., & Αγοραστός, Θ. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2017.1323197 · Cited by 16

PCR-RFLP assay as an option for primary HPV test

Golfetto, L., Alves, E. V., Martins, T. R., Sincero, T. C. M., Castro, J. B. S., Dannebrock, C., de Oliveira, J. G., Levi, J. E., Onofre, A. S. C., & Bazzo, M. L. (2018) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20177098 · Cited by 16

Increased risk of HPV‐associated genital cancers in men and women as a consequence of pre‐invasive disease

Pan, J., Kavanagh, K., Cuschieri, K. S., Pollock, K. G. J., Gilbert, D. C., Millan, D. W. M., Bell, S., Graham, S. V., Williams, A. R. W., Cruickshank, M. E., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32126 · Cited by 16

Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia

Velentzis, L. S., Smith, M. A., Simms, K. T., Lew, J., Hall, M. T., Hughes, S., Yuill, S., Killen, J., Keane, A., Butler, K. A., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.12.019 · Cited by 16

Risk of CIN2 or more severe lesions after negative HPV‐mRNA E6/E7 overexpression assay and after negative HPV‐DNA test: Concurrent cohorts with a 5‐year follow‐up

Zorzi, M., Mistro, A. D., Rossi, P. G., Laurino, L., Battagello, J., Lorio, M., Soldà, M., Gabellotti, E. M., Maran, M., Cin, A. D., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32695 · Cited by 16

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer

Inturrisi, F., Lissenberg-Witte, B. I., Veldhuijzen, N. J., Bogaards, J. A., Ronco, G., Meijer, C. J. L. M., & Berkhof, J. H. (2020) · International Journal of Cancer · doi:10.1002/ijc.33207 · Cited by 16

A hidden Markov model for population‐level cervical cancer screening data

Soper, B., Nygård, M., Abdulla, G. M., Meng, R., & Nygård, J. F. (2020) · Statistics in Medicine · doi:10.1002/sim.8681 · Cited by 16

Evaluating the Performance of p16INK4a Immunocytochemistry in Cervical Cancer Screening

Song, F., Du, H., Xiao, A., Wang, C., Huang, X., Yan, P., Liu, Z., Qu, X., Belinson, J. L., & Wu, R. (2020) · Cancer Management and Research · doi:10.2147/cmar.s273079 · Cited by 16

Women’s acceptability of and experience with primary human papillomavirus testing for cervix screening: HPV FOCAL trial cross-sectional online survey results

Smith, L., Racey, C. S., Gondara, L., Krajden, M., Lee, M. H., Martin, R. E., Stuart, G. C. E., Peacock, S. J., Coldman, A. J., Franco, E. L., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-052084 · Cited by 16

Epidemiologie, Prävention und Früherkennung des Zervixkarzinoms

Wentzensen, N. (2016) · Der Onkologe · doi:10.1007/s00761-016-0092-7 · Cited by 16

Genetic and Environmental Factors in Invasive Cervical Cancer: Design and Methods of a Classical Twin Study

Machalek, D. A., Wark, J. D., Tabrizi, S. N., Hopper, J. L., Bui, M., Dite, G. S., Cornall, A. M., Pitts, M. K., Gertig, D. M., Erbas, B., et al. (2016) · Twin Research and Human Genetics · doi:10.1017/thg.2016.93 · Cited by 16

Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study

Chatzistamatiou, Κ., Moysiadis, T., Angelis, E., Kaufmann, A. M., Skenderi, A., Jansen‐Dürr, P., Lekka, I., Kilintzis, V., Angelidou, S., Katsiki, E., et al. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4324-x · Cited by 16

Human papillomavirus E7 protein detection as a method of triage to colposcopy of HPV positive women, in comparison to genotyping and cytology. Final results of the PIPAVIR study

Αγοραστός, Θ., Chatzistamatiou, Κ., Moysiadis, T., Kaufmann, A. M., Skenderi, A., Lekka, I., Koch, I., Soutschek, E., Boecher, O., Kilintzis, V., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30761 · Cited by 16

Influence of Prior Knowledge of Human Papillomavirus Status on the Performance of Cytology Screening

Martins, T. R., Longatto‐Filho, A., Cohen, D. D., Viscondi, J. Y. K., Fuza, L. M., Cury, L., Villa, L. L., Levi, J. E., & Eluf‐Neto, J. (2017) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqx163 · Cited by 16

Economic evaluation of HPV DNA test as primary screening method for cervical cancer: A health policy discussion in Greece

Skroumpelos, A., Αγοραστός, Θ., Constantinidis, T. C., Chatzistamatiou, Κ., & Kyriopoulos, J. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226335 · Cited by 16

Evaluation and Optimization of the Clinical Accuracy of Hybribio's 14 High-Risk HPV with 16/18 Genotyping Assay within the VALGENT-3 Framework

Xu, L., Oštrbenk, A., Poljak, M., & Arbyn, M. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00234-20 · Cited by 16

The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening

Song, F., Du, H., Wang, C., Huang, X., Qu, X., Wei, L., Belinson, J. L., Wu, R., & CHIMUST team (2020) · Journal of Medical Screening · doi:10.1177/0969141320943634 · Cited by 16

Determinants of Viral Oncogene E6-E7 mRNA Overexpression in a Population-Based Large Sample of Women Infected by High-Risk Human Papillomavirus Types

Rossi, P. G., Bisanzi, S., Allìa, E., Mongia, A., Carozzi, F., Gillio‐Tos, A., Marco, L. D., Ronco, G., Gustinucci, D., Mistro, A. D., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01794-16 · Cited by 16

Multiplex recombinase polymerase amplification for high-risk and low-risk type HPV detection, as potential local use in single tube

Wongsamart, R., Bhattarakasol, P., Chaiwongkot, A., Wongsawaeng, D., Okada, P. A., Palaga, T., Leelahavanichkul, A., Khovidhunkit, W., Dean, D., & Somboonna, N. (2023) · Scientific Reports · doi:10.1038/s41598-023-28038-9 · Cited by 15

Molecular markers predicting the progression and prognosis of human papillomavirus-induced cervical lesions to cervical cancer

Amin, F. A. S., Naher, Z. U., & Ali, P. S. S. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04710-5 · Cited by 15

Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations

Zigras, T., Mayrand, M., Bouchard, C., Salvador, S., Eiriksson, L. R., Almadin, C., Kean, S., Dean, E. A., Malhotra, U., Todd, N. J., et al. (2023) · Current Oncology · doi:10.3390/curroncol30060425 · Cited by 15

The Association of Cervical Cancer Screening With Disability Type Among U.S. Women (Aged 25–64 Years)

Orji, A. F., Gimm, G. W., Desai, A. P., & Parekh, T. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.08.010 · Cited by 16

p16/Ki67 dual stain triage versus cytology in primary human papillomavirus‐based cervical cancer screening with limited genotyping

Trzeszcz, M., Mazurec, M., Jach, R., Mazurec, K., Kotkowska‐Szeps, I., Kania, M., Wantuchowicz, M., Wasowska, J., Duczek‐Polakiewicz, M., Rozmus, P., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29271 · Cited by 15

CRISPR-Cas12a-enhanced mass spectrometric DNA nanomachine for HPV-16 detection in human serum

Hu, Y., Liu, L., Wang, C., Zhou, J., Liu, R., & Lv, Y. (2023) · Chemical Communications · doi:10.1039/d3cc05949a · Cited by 16

Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening

Rebolj, M., Brentnall, A. R., & Cuschieri, K. S. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02681-z · Cited by 15

Association of female genital schistosomiasis and human papillomavirus and cervical pre-cancer: a systematic review

Sturt, A. S., Omar, T., Hansingo, I., Kamfwa, P., Bustinduy, A. L., & Kelly, H. A. (2025) · BMC Women s Health · doi:10.1186/s12905-024-03514-0 · Cited by 15

Cervical cancer screening in the era of HPV vaccination: A review of shifting paradigms in cytopathology

Barroeta, J. E., Adhikari‐Guragain, D., & Grotkowski, C. E. (2017) · Diagnostic Cytopathology · doi:10.1002/dc.23737 · Cited by 15

Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening

Iacobellis, M., Violante, C., Notarachille, G., Simone, A., Scarfì, R., & Giuffrè, G. (2018) · Virology Journal · doi:10.1186/s12985-018-0965-z · Cited by 15

Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis

Conrad, R. D., Liu, A. H.-C., Wentzensen, N., Zhang, R. R., Dunn, S. T., WANG, S. S., SCHIFFMAN, M. H., Gold, M. A., Walker, J. L., & Zuna, R. E. (2018) · Cancer Cytopathology · doi:10.1002/cncy.22055 · Cited by 15

Exploring women's preferences for HPV‐based cervical cancer screening in South Africa

Oberlin, A. M., Pasipamire, T., & Chibwesha, C. J. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12869 · Cited by 15

Efficacy of HPV-Based Screening for Prevention of Invasive Cervical Cancer

Ronco, G., Dillner, J., Elfström, K. M., Tùnesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H. C., Segnan, N., Gilham, C., Rossi, P. G., et al. (2014) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000453824.69728.c0 · Cited by 6

Embracing a new era in cervical cancer screening

Isidean, S. D., & Franco, E. L. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62028-0 · Cited by 18

Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden

Wang, J., Elfström, K. M., & Dillner, J. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00218-4 · Cited by 63

Evaluation of primary HPV-based cervical screening among older women: Long-term follow-up of a randomized healthcare policy trial in Sweden

Yao, Q. Y., Wang, J., Elfström, M. K., Strander, B., Dillner, J., & Sundström, K. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004505 · Cited by 6

HPV screening offers greater protection against invasive cervical cancer than cytology, finds analysis

Kmietowicz, Z. (2013) · BMJ · doi:10.1136/bmj.f6624